Ograniczanie wyników

Czasopisma help

  1. 15 Archivum Immunologiae et Therapiae Experimentalis

  2. 8 Journal of Physiology and Pharmacology. Supplement

  3. 6 Journal of Physiology and Pharmacology

  4. 5 Folia Histochemica et Cytobiologica

  5. 2 Bulletin of the Veterinary Institute in Puławy

Więcej...
Autorzy help

  1. 2 Demkow U.

  2. 2 Dzaman K.

  3. 2 Filewska M.

  4. 2 Krzeski A.

  5. 2 Molinska-Glura M.

Więcej...
Lata help

  1. 3 2020

  2. 2 2019

  3. 3 2018

  4. 2 2017

  5. 2 2016

Więcej...
Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 39

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  chronic inflammation
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9

100%
Grzela K., Litwiniuk M., Zagorska W., Grzela T.
Archivum Immunologiae et Therapiae Experimentalis
|
2016
|
tom 64
|
nr 1
2

Pericardium: structure and function in health and disease

100%
Jaworska-Wilczynska M., Trzaskoma P., Szczepankiewicz A. A., Hryniewiecki T.
Folia Histochemica et Cytobiologica
|
2016
|
tom 54
|
nr 3
3

Bronchial hyper-responsiveness, subepithelial fibrosis, and transforming growth factor-beta1 expression in patients with long-standing and recently diagnosed asthma

100%
Tomkowicz A., Kraus-Filarska M., Bar J., Rabczynski J., Jelen M., Piesiak P., Fal A., Panaszek B.
Archivum Immunologiae et Therapiae Experimentalis
|
2008
|
tom 56
|
nr 6
401-408
4

Non-specific inflammatory bowel diseases and the risk of tumour growth

100%
Dudzinska E., Gryzinska M., Ognik K., Krauze M., Listos P.
Medycyna Weterynaryjna
|
2018
|
tom 74
|
nr 04
Inflammatory bowel disease (IBD), which includes mainly ulcerative colitis (UC) and Crohn’s disease (Lesniowski-Crohn’s, ChL-C, CD), is a chronic and recurrent inflammatory condition of the gastrointestinal tract with multifactorial causes. Both types of IBD are characterized by chronic inflammation with periods of remission and exacerbation. An increasing number of studies have recently shown that chronic inflammation plays an important role in the carcinogenesis of colorectal cancer (CRC), generating suitable microenvironments for the formation and progression of the disease. The main factors are chronic inflammation as well as the scope and duration of the disease. The pro-inflammatory interleukins IL-13, IL-8 and TNF-α play an important role in tumorigenesis. It is further emphasized that reactive oxygen species (ROS) and reactive nitrogen species produced by inflammatory cells may interact with key genes involved in carcinogenic pathways, such as TP53. Carcinogenesis in IBD involves proteins determined by the genes DLG5, OCTN and NOD2. Immunosuppressive drugs, such as thiopurines and methotrexate, may play a role in extra-intestinal tumour development by impairing the immune system and surveillance of tumour cells or by inducing DNA damage. Recognition of neoplastic changes associated with IBD is difficult due to the heterogeneity of the endoscopic image and variation in the diagnosis depending on the observer. Therefore surveillance of IBD patients by a multidisciplinary team is essential for early detection of the neoplastic process.
5

Evaluation of endothelial function by flow-mediated dilation: a comprehensive review in rheumatic disease

84%
Moroni L., Selmi C., Angelini C., Meroni P. L.
Archivum Immunologiae et Therapiae Experimentalis
|
2017
|
tom 65
|
nr 6
6

Trichuris suis secrete products that reduce disease severity in a multiple sclerosis model

84%
Hansen C. S., Hasseldam H., Bacher I. H., Thamsborg S. M., Johansen F. F., Kringel H.
Acta Parasitologica
|
2017
|
tom 62
|
nr 1
7

Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps

84%
Dzaman K., Szczepanski M. J., Molinska-Glura M., Krzeski A., Zagor M.
Archivum Immunologiae et Therapiae Experimentalis
|
2015
|
tom 63
|
nr 3
8

The phenomenon of neutrophil extracellular traps in vascular diseases

84%
Dabrowska D., Jablonska E., Garley M., Sawicka-Powierza J., Nowak K.
Archivum Immunologiae et Therapiae Experimentalis
|
2018
|
tom 66
|
nr 4
9

The reverse-direction method links mass experimental data to human diseases

84%
Ogura H., Atsumi T., Bando H., Sabharwal L., Yamada M., Jiang J.-J., Nakamura A., Arima Y., Kamimura D., Murakami M.
Archivum Immunologiae et Therapiae Experimentalis
|
2014
|
tom 62
|
nr 1
10

Systemic treatment for severe atopic dermatitis

84%
Giavina-Bianchi M., Giavina-Bianchi P.
Archivum Immunologiae et Therapiae Experimentalis
|
2019
|
tom 67
|
nr 2
11

IL-6 contributes to the TGF-beta1-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells

84%
Sisto M., Tamma R., Ribatti D., Lisi S.
Archivum Immunologiae et Therapiae Experimentalis
|
2020
|
tom 68
|
nr 5
12

High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps

84%
Dzaman K., Zagor M., Molinska-Glura M., Krzeski A.
Folia Histochemica et Cytobiologica
|
2015
|
tom 53
|
nr 1
13
Content available remote

Interleukin-6 deficiency modifies the effect of high fat diet on myocardial expression of fatty acid transporters and myocardial lipids

84%
Mysliwiec P., Choromanska B., Winnicka M. M., Kaminski K., Mysliwiec H., Dadan J., Supruniuk E., Chabowski A.
Journal of Physiology and Pharmacology
|
2018
|
tom 69
|
nr 4
14
Content available remote

Association of anticardiolipin antibodies, complement and leptin with the severity of coronary artery disease expressed as SYNTAX score

84%
Runjic F., Martinovic-Kaliterna D., Salamunic I., Kristic I., Ljubkovic M., Marinovic J.
Journal of Physiology and Pharmacology
|
2020
|
tom 71
|
nr 3
15
Content available remote

NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin

84%
Konturek P. C., Kania J., Burnat G., Hahn E. G.
Journal of Physiology and Pharmacology. Supplement
|
2006
|
tom 57
|
nr 12
15-24
Expression of cyclooxygenase-2 (COX-2) is involved in the chronic inflammation-related development of Barrett’s adenocarcinoma and the use of selective COX-2 inhibitors (coxibs) might provide new chemoprevention strategy for Barrett’s adenocarcinoma (BA). Despite an excellent gastrointestinal (GI) safety profile of coxibs, their use is limited because of the possible cardiovascular complications. The coupling of NSAIDs with a NO-donating moiety has led to the birth of a new class of anti-inflammatory drugs, called the COX-inhibiting nitric oxide donators (CINODs). The member of this group, NO-aspirin (NO-ASA) retains the anti-inflammatory properties of traditional aspirin (ASA), but the release of NO accounts for anti-thromboembolic effect and better GI safety profile. The role of NO-ASA in the prevention of Barrett’s adenocarcinoma (BA) has not been studied so far. Therefore, the aim of the present study was: 1) to analyse the expression of COX-2 in the biopsies obtained from BE; 2) to compare the effect of NO-ASA with that of ASA on proliferation rate in Barrett’s adenocarcinoma cell line (OE-33 cells); 3) to determine the effect of both compounds on the apoptosis rate using FACS analysis and expression of 32-kDa procaspase-3 and active proapoptotic 20-kDa caspase-3 in OE-33 cell line. The expression of COX-2 was assessed in biopsies obtained from the Barrett’s mucosa and normal squamous epithelial esophageal mucosa from 20 BE patients by RT-PCR and Western blot analysis, respectively. The BA cell line (OE-33) was incubated with NO-ASA or ASA (10-1000µM). The cell proliferation and apoptosis rate was measured by BrdU and FACS-analysis, respectively. The expression of caspase-3 (active and inactive form) was analyzed by Western blot. In Barrett’s mucosa a significant up-regulation of COX-2 was observed. Compared with traditional ASA, NO-ASA caused a significantly stronger induction of apoptosis (dose-dependently). Inhibition of cell proliferation in OE-33 cells observed under NO-ASA treatment was due to the apoptosis induction. The increase in apoptotic rate was accompanied by the upregulation of active 20-kDa caspase-3. At the highest concentration (1000µM), a necrotic death of OE-33 cells was observed under NO-ASA treatment. We conclude that: NO-ASA caused induction of apoptosis in BA cell line and slight growth inhibition. These results indicate that this compound may represent a promising chemopreventive agent for Barrett’s adenocarcinoma.
16

Activity of LDH isoenzymes in diarrhoeic calves

84%
Sobiech P., Kuleta Z.
Bulletin of the Veterinary Institute in Puławy
|
2006
|
tom 50
|
nr 3
17

Serological examinations in patients with Helicobacter pylori infections

84%
Gosciniak G., Przondo-Mordarska A., Matysiak-Budnik T., Knapik Z.
Archivum Immunologiae et Therapiae Experimentalis
|
1993
|
tom 41
|
nr 5-6
18

Factors underlying chronic inflammation in rheumatoid arthritis

84%
Wong S. H., Lord J. M.
Archivum Immunologiae et Therapiae Experimentalis
|
2004
|
tom 52
|
nr 6
19
Content available remote

Oxidative stress and inflammatory markers in prediabetes and diabetes

67%
Luc K., Schramm-Luc A., Guzik T. J., Mikolajczyk T. P.
Journal of Physiology and Pharmacology
|
2019
|
tom 70
|
nr 6
20

Evaluation of agreement of the ELISA and AGID tests in the diagnostics of caprine arthritis-encephalitis

67%
Kaba J., Ganter M., Rypula K., Frymus T.
Electronic Journal of Polish Agricultural Universities. Series Veterinary Medicine
|
2004
|
tom 07
|
nr 1
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.